Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
TetraLogic
(OTCEM:TLOG)
Intraday
$0.0001
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0001
0
[0.00%]
At close: Dec 13
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for TetraLogic Stock (OTC:TLOG)
TetraLogic Stock (OTC: TLOG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
-
Mar 24, 2020, 11:35AM
Thursday, August 08, 2019
Stocks That Set New 52-Week Highs Thursday
Lisa Levin
-
Aug 8, 2019, 12:19PM
Wednesday, November 02, 2016
TetraLogic Agrees To Sell Assets To Medivir And Delisting Of Common Stock
Benzinga
-
Nov 2, 2016, 5:12PM
TetraLogic Pharmaceuticals Halted; Pending News
Benzinga
-
Nov 2, 2016, 4:40PM
TetraLogic Pharma Shares Halted News Pending
Benzinga
-
Nov 2, 2016, 4:37PM
Tuesday, June 21, 2016
Worst Performing Industries For June 21, 2016
Benzinga
-
Jun 21, 2016, 11:13AM
Thursday, April 07, 2016
Tetralogic Pharma Says CFO/Treasurer Pete Meyers To Step Down April 30 2016, Pat Hutchinson To Be SVP, Finance, As CFO & Treasurer Of Co
Benzinga
-
Apr 7, 2016, 4:11PM
Thursday, January 07, 2016
Here's Why Tetralogic Pharmaceuticals Is Down 70%
Benzinga
-
Jan 7, 2016, 8:41AM
Wednesday, January 06, 2016
TetraLogic Pharma Shares Continue To Fall After Hours, Down 70% Following Discontinued Phase II Trial
Benzinga
-
Jan 6, 2016, 4:50PM
UPDATE: TetraLogic Pharmaceuticals birinapant Did Not Demonstrate Clinical Benefit Over Placebon ON Primary Endpoint, Study Will Be Terminated
Benzinga
-
Jan 6, 2016, 4:12PM
TetraLogic Pharmaceuticals Says Birinapant Shows No Activity in Randomized Phase 2 MDS Study; SHAPE Shows Clinical Benefit in Randomized Phase 2 CTCL Study
Benzinga
-
Jan 6, 2016, 4:11PM
Tetralogic Shares Halted News Pending
Benzinga
-
Jan 6, 2016, 4:03PM
Thursday, December 31, 2015
Roth Capital's New Buy Rating On TetraLogic: 'SMAC'ing Cancer Around'
Benzinga
-
Dec 31, 2015, 8:30AM
Wednesday, December 30, 2015
UPDATE: Roth Capital Says TetraLogic's Birinapant And SHAPE Data Supports Positive Phase II Study Read Out
Benzinga
-
Dec 30, 2015, 4:19PM
Roth Capital Initiates Coverage on TetraLogic Pharmaceutical at Buy, Announces $5.00 PT
Benzinga
-
Dec 30, 2015, 4:17PM
Tuesday, December 01, 2015
Tetralogic Pharma Shares Sell Off Below $2, Down ~$0.40 In Past Minute
Benzinga
-
Dec 1, 2015, 10:10AM
Tuesday, August 25, 2015
Tetralogic Pharma Announces Lincoln Park Capital Can Purchase up to $17M of Common Stock
Benzinga
-
Aug 25, 2015, 6:08AM
Monday, August 24, 2015
Morning Market Losers
Benzinga
-
Aug 24, 2015, 9:49AM
Wednesday, August 05, 2015
TetraLogic Pharma Reports Q2 Loss $0.51 Vs Est Loss $0.47
Benzinga
-
Aug 5, 2015, 4:26PM
Monday, July 20, 2015
TetraLogic Gives Update on Hepatitis B Clinical Program
Benzinga
-
Jul 20, 2015, 4:02PM
Monday, July 06, 2015
Tetralogic Pharmaceuticals Director Schmitt Buys 10,000 Shares @$2.34/Share -Form 4
Benzinga
-
Jul 6, 2015, 2:26PM
Wednesday, July 01, 2015
Mid-Day Market Update: Chubb Surges Following Announcement of Acquisition by Ace; Ballard Power Shares Decline
Benzinga
-
Jul 1, 2015, 1:39PM
Mid-Morning Market Update: Markets Open Higher; Constellation Brands Q1 Profit Tops Views
Benzinga
-
Jul 1, 2015, 10:36AM
Morning Market Gainers
Benzinga
-
Jul 1, 2015, 9:41AM
Tuesday, June 30, 2015
Tetralogic, Freeport-McMoRan, Melco Crown Lead Tuesday's After-Hours Movers
Benzinga
-
Jun 30, 2015, 5:21PM
TetraLogic Announces Update on MDS Clinical Program
Benzinga
-
Jun 30, 2015, 4:02PM
Wednesday, May 06, 2015
PREVIEW: TetraLogic Pharmaceuticals to Resume Trading at 2:30 PM ET
Benzinga
-
May 6, 2015, 2:21PM
TetraLogic Announces Termination of Public Offering
Benzinga
-
May 6, 2015, 12:53PM
TetraLogic Shares Halted News Pending
Benzinga
-
May 6, 2015, 12:39PM
Shares of TetraLogic Resume Trade Following Second Circuit Breaker, Stock Now Down ~47%
Benzinga
-
May 6, 2015, 10:56AM
TetraLogic Shares Halted on Second Circuit Breaker
Benzinga
-
May 6, 2015, 10:52AM
Shares of TetraLogic Resume Trade Following Circuit Breaker, Now Down ~47%
Benzinga
-
May 6, 2015, 10:51AM
Shares of TetraLogic Halted on Circuit Breaker
Benzinga
-
May 6, 2015, 10:46AM
TetraLogic Pharma Shares Resume Trade, Plunge 55+%
Benzinga
-
May 6, 2015, 10:45AM
Shares of TetraLogic to Resume Trade at 10:45 a.m. EDT
Benzinga
-
May 6, 2015, 10:23AM
UPDATE: TetraLogic Reports Temporary Halt of Chronic Hep B Trial
Benzinga
-
May 6, 2015, 10:15AM
TetraLogic Reports Temporary Halt of Chronic Hep B Trial
Benzinga
-
May 6, 2015, 10:15AM
Shares of TetraLogic Halted News Pending
Benzinga
-
May 6, 2015, 10:00AM
Friday, May 01, 2015
Morning Market Losers
Benzinga
-
May 1, 2015, 10:03AM
Tetralogic Prices 6.25M Shares at $4/Share
Benzinga
-
May 1, 2015, 8:57AM
Benzinga's Top #PreMarket Losers
Benzinga
-
May 1, 2015, 8:26AM
Monday, April 20, 2015
Morning Market Gainers
Benzinga
-
Apr 20, 2015, 9:41AM
Tetralogic Announces Co., Merck Will Collaborate Related to Evaluation of Birinapant In Combo With KEYTRUDA in Solid Tumors
Benzinga
-
Apr 20, 2015, 8:05AM
Thursday, February 26, 2015
TetraLogic Pharma Reports Q4 EPS -$0.53 Vs Est. -$0.39
Benzinga
-
Feb 26, 2015, 4:21PM
Friday, January 09, 2015
Tetralogic Pharmaceuticals CEO Buchi Buys 5,000 Shares @$5.04/Share -Form 4
Benzinga
-
Jan 9, 2015, 7:13AM
Friday, January 02, 2015
Tetralogic Pharma Files $150M Mixed Securities Shelf According to S-3
Benzinga
-
Jan 2, 2015, 1:07PM
Thursday, December 18, 2014
US Stock Futures Signal Higher Start On Wall Street
Benzinga
-
Dec 18, 2014, 7:35AM
TetraLogic Reports Initiation of Randomized Phase 2 Trial of SHAPE for Cutaneous T-Cell Lymphoma
Benzinga
-
Dec 18, 2014, 7:21AM
Tuesday, December 16, 2014
TetraLogic Provides Update on Ovarian Cancer Study
Benzinga
-
Dec 16, 2014, 7:01AM
Thursday, November 13, 2014
Tetralogic Pharmaceuticals CFO Meyers Buys 5,000 Shares @$3.98/Share -Form 4
Benzinga
-
Nov 13, 2014, 2:22PM
Show more